Status:
COMPLETED
Music Therapy to Address Patients' Journeys With Chronic Illness, Outcomes, and Readmission - MAJOR CHORD RCT
Lead Sponsor:
Samuel Rodgers-Melnick
Collaborating Sponsors:
Kulas Foundation
Conditions:
Heart Failure
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
30-89 years
Phase:
NA
Brief Summary
Conduct a randomized trial (n = 60: with n = 30 receiving music therapy and n = 30 receiving usual care) to investigate the feasibility, acceptability, and preliminary efficacy of the MAJOR CHORD musi...
Detailed Description
For the intervention arm, in-person sessions will be conducted at the discretion of the music therapist and at a convenient time for the participant. Post-discharge music therapy sessions will be cond...
Eligibility Criteria
Inclusion
- Randomized Control Trial
- Age range: ≥30 to ≤89 years
- Primary indication for current hospitalization is either COPD or HF with confirmed ICD-10 code in the electronic health record (EHR)
- Able to read and understand English
- Hospitalized at UH Cleveland Medical Center (UHCMC) with anticipated length of stay following recruitment ≥ 2 days as documented in electronic health record (EHR) and confirmed by the clinical care team
- Access to Wi-Fi, active email address, \& laptop, tablet, smartphone, and/or PC with videoconferencing capabilities at home or the facility in which they will be discharged
- Has reliable access to a mobile device with an active data plan at the hospital and at home and is comfortable accessing the internet and their email with this device
- Qualitative Interview Inclusion Criteria 1. Agreed to be contacted for the qualitative interview during contenting process for the RCT
Exclusion
- Active confirmed or suspected COVID-19, or under droplet, contact, MRSA, and/or C.diff precaution notification as documented in the EHR
- Included on the Music Therapy Referral patient list in the EHR
- Significant hearing and/or visual impairment as documented in EHR
- Unable to independently provide consent (i.e., no proxy consent)
- Active suicidal ideation as documented in EHR during current hospital admission
- Severe psychological comorbidity (e.g., psychosis, schizophrenia) that would prevent patient from engaging fully in intervention as documented in EHR
- Receiving active cancer treatment (e.g., chemotherapy, radiation, immunotherapy) as documented in EHR
- Diagnosed with medical condition likely to be terminal within 24 weeks as documented in EHR
- On wait list for heart transplantation or ventricular assist device (VAD) as documented in EHR
- NYHA Stage IV HF or end-stage COPD as documented in EHR
- Receiving hospice care as documented in EHR
- Active substance abuse as documented in EHR
- Has end stage renal disease or is currently receiving dialysis
- Qualitative Interview Exclusion Criteria
- 1\. Randomized to the control arm
Key Trial Info
Start Date :
August 26 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 17 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06546319
Start Date
August 26 2024
End Date
June 17 2025
Last Update
August 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States, 44106